EUVIMEDEUVIMED entdecken
Crossref

Germline Mutation Landscape of Neuroendocrine Tumors in the Chinese Population

Yuting Sun iD, Lin Dong iD, Huijing Tan, Dongbing Zhao iD, Hong Zhao, Jianming Ying, Yihebali Chi

International Journal of Cancer · 15.08.2026 · 159 (4) · 915-923

DOI: 10.1002/ijc.70482 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, online erschienen am 09.04.2026. Verfasst von Yuting Sun und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Scien…. Hauptthemen laut MEDLINE: Germ-Line Mutation, Neuroendocrine Tumors. Die Arbeit nennt 38 Literaturangaben. Gefördert von: Wu Jieping Medical Foundation of China, CAMS Innovation Fund for Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Certain hereditary syndromes increase the incidence of neuroendocrine tumors (NETs), suggesting germline variation may play a role in NET pathogenesis. However, the germline mutation spectrum in Chinese NET patients remains unclear. This study aimed to investigate the germline genetic variations and associated clinicopathological features in Chinese NET patients. A single‐center retrospective study was conducted at the Cancer Hospital of Chinese Academy of Medical Sciences; 453 histologically confirmed NET patients who received germline genetic testing between June 2018 and March 2025 were enrolled. Germline DNA extracted from saliva or blood samples was analyzed using multigene panels and whole‐exome sequencing. Results showed 11.5% (52/453) cases carried germline pathogenic or likely pathogenic variants (P/LPVs) across 28 cancer predisposing genes. MEN1 was the most frequently mutated gene, accounting for 3.5% (16/453) of all enrolled patients, followed by PALB2 , SDHB , and BRIP1 . The most common variant of uncertain significance (VUS) was found in MUTYH . Compared with non‐carriers, P/LPV carriers were characterized by a significantly younger age at diagnosis ( p < 0.001), male predominance ( p = 0.008), higher tumor grade ( p = 0.006), a stronger family history of cancer ( p = 0.047), different primary tumor locations ( p < 0.001), lower somatostatin receptor 2 expression ( p = 0.010), and more aggressive tumor behavior, including higher metastatic rate ( p = 0.002) and advanced stage ( p = 0.011). Furthermore, patients with MEN1 P/LPVs had more mediastinal tumors and a younger age than those with non‐MEN1 P/LPVs. This study, which is the largest to date regarding germline variations in Chinese patients with NETs, reveals a distinct mutational profile and identifies the unique clinicopathological features among carriers of germline P/LPVs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Germ-Line MutationNeuroendocrine TumorsAdolescentAdultAgedFemaleHumansMaleMiddle AgedYoung AdultChinaGenetic Predisposition to DiseaseRetrospective StudiesEast Asian People

Stichwörter der Autor:innen

cancer predisposing genesgermline mutationneuroendocrine tumorspathogenic or likely pathogenic variant

Autor:innen und Institutionen

  • Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Department of Pancreatic and Gastric Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing,…
  • Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

ORCID-Profile: Yuting Sun, Lin Dong, Dongbing Zhao

Förderung

  • Wu Jieping Medical Foundation of China
  • CAMS Innovation Fund for Medical Sciences

Zitieren

APA

Sun, Y., Dong, L., Tan, H., Zhao, D., Zhao, H., Ying, J., & Chi, Y. (2026). Germline Mutation Landscape of Neuroendocrine Tumors in the Chinese Population. International Journal of Cancer, 159(4), 915-923. https://doi.org/10.1002/ijc.70482

Vancouver

Sun Y, Dong L, Tan H, Zhao D, Zhao H, Ying J, et al. Germline Mutation Landscape of Neuroendocrine Tumors in the Chinese Population. International Journal of Cancer. 2026;159(4):915-923. doi:10.1002/ijc.70482

BibTeX
@article{Sun2026,
  author = {Sun, Yuting and Dong, Lin and Tan, Huijing and Zhao, Dongbing and Zhao, Hong and Ying, Jianming and Chi, Yihebali},
  title = {Germline Mutation Landscape of Neuroendocrine Tumors in the Chinese Population},
  journal = {International Journal of Cancer},
  year = {2026},
  volume = {159},
  number = {4},
  pages = {915--923},
  doi = {10.1002/ijc.70482}
}
Kostenlos starten →